Department of Pediatrics, Universityof Miami Leonard M. Miller School of Medicine, FL, USA.
JAMA Pediatr. 2013 Jun;167(6):520-7. doi: 10.1001/jamapediatrics.2013.1206.
Prior to contemporary antiretroviral therapies (ARTs), children infected with human immunodeficiency virus (HIV) were more likely to have heart failure. This study suggests that highly active ART (HAART) does not appear to impair heart function.
To determine the cardiac effects of prolonged exposure to HAART on HIV-infected children.
In the National Institutes of Health-funded Pediatric HIV/AIDS Cohort Study's Adolescent Master Protocol (AMP), we used linear regression models to compare echocardiographic measures.
A total of 14 US pediatric HIV clinics.
Perinatally HIV-infected children receiving HAART (n = 325), HIV-exposed but uninfected children (n = 189), and HIV-infected (mostly HAART-unexposed) historical pediatric controls from the National Institutes of Health-funded Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2-HIV) Study (n = 70). EXPOSURE Long-term HAART.
Echocardiographic measures of left ventricular (LV) function and structure.
The 325 AMP HIV-infected children had lower viral loads, higher CD4 counts, and longer durations of ART than did the 70 HIV-infected children from the P2C2-HIV Study (all P < .001). The z scores for LV fractional shortening (a measure of cardiac function) were significantly lower among HIV-infected children from the P2C2-HIV Study than among the AMP HIV-infected group or the 189 AMP HIV-exposed but uninfected controls (P < .05). For HIV-infected children, a lower nadir CD4 percentage and a higher current viral load were associated with significantly lower cardiac function (LV contractility and LV fractional shortening z scores; all P = .001) and an increased LV end-systolic dimension z score (all P < .03). In an interaction analysis by HIV-infected cohort, the HIV-infected children from the P2C2-HIV Study with a longer ART exposure or a lower nadir CD4 percentage had lower mean LV fractional shortening z scores, whereas the mean z scores were relatively constant among AMP HIV-infected children (P < .05 for all interactions).
Long-term HAART appears to be cardioprotective for HIV-infected children and adolescents.
在当代抗逆转录病毒疗法(ART)出现之前,感染人类免疫缺陷病毒(HIV)的儿童更有可能出现心力衰竭。本研究表明,高效抗逆转录病毒治疗(HAART)似乎不会损害心脏功能。
确定长期接受 HAART 对 HIV 感染儿童的心脏影响。
在由美国国立卫生研究院(NIH)资助的儿科 HIV/AIDS 队列研究的青少年主方案(AMP)中,我们使用线性回归模型来比较超声心动图测量结果。
美国 14 家儿科 HIV 诊所。
接受 HAART 的围生期 HIV 感染儿童(n = 325)、HIV 暴露但未感染儿童(n = 189)和来自 NIH 资助的肺和心血管并发症垂直传播 HIV 感染研究(P2C2-HIV)的 HIV 感染(大多未接受 HAART)历史儿科对照(n = 70)。
长期 HAART。
左心室(LV)功能和结构的超声心动图测量。
AMP 中 325 名 HIV 感染儿童的病毒载量较低,CD4 计数较高,ART 持续时间较长,而来自 P2C2-HIV 研究的 70 名 HIV 感染儿童则较低(均 P <.001)。来自 P2C2-HIV 研究的 HIV 感染儿童的 LV 短缩分数(心脏功能的一项测量指标)z 评分明显低于 AMP HIV 感染组或 189 名 AMP HIV 暴露但未感染对照组(P <.05)。对于 HIV 感染儿童,较低的 CD4 百分比最低点和较高的当前病毒载量与心脏功能(LV 收缩力和 LV 短缩分数 z 评分)显著降低以及 LV 收缩末期内径 z 评分增加相关(均 P =.001)。在按 HIV 感染队列进行的交互分析中,P2C2-HIV 研究中接受 HAART 时间较长或 CD4 百分比最低点较低的 HIV 感染儿童的平均 LV 短缩分数 z 评分较低,而 AMP HIV 感染儿童的平均 z 评分相对恒定(所有交互作用 P <.05)。
长期 HAART 似乎对 HIV 感染的儿童和青少年具有心脏保护作用。